🔴 Edesa Biotech is trading 6.3% down today after pricing $25 million offering

Edesa Biotech is trading at $4.46, down -6.30% after pricing a $25 million underwritten public offering of shares, pre-funded warrants, and accompanying warrants.

• Financing includes 3.87 million shares and up to 675,000 pre-funded warrants, creating dilution pressure.
• Warrants are exercisable at $7.50 per share, while offering units were priced at $5.50.
• Shares have also fallen from $4.76 on August 20 after the financing announcement.